Syra Health

Syra Health Wins a Healthcare Workforce Contract from Douglas County, Nebraska

The contract marks the Company’s expansion into its 16th state

CARMEL, IN, February 22, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been awarded a healthcare workforce contract to provide temporary nursing staffing services in support of Douglas County, Nebraska, which includes the state’s largest city, Omaha.

"This latest contract underscores our commitment to advancing healthcare accessibility and quality. Together with the Douglas County community, we look forward to delivering exceptional healthcare services. This achievement reflects our dedication to making a meaningful impact on the well-being of individuals and families,” said Dr. Deepika Vuppalanchi, CEO, Syra Health.

Revenue generated from this contract is dependent on the number of positions Syra Health will staff and the duration of the positions. This contract marks the sixteenth state that Syra Health now has active healthcare workforce contracts in. The company sells multiple products and services in several of the 16 states.


Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health by providing innovative services and technology solutions. Syra Health’s products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and the government. For more information, please visit


Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company’s operations and business strategy and the Company’s expected financial results. The words "anticipate," "believe," "continue," "could,"

"estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:

Christine Drury

Communications and Marketing Director

Syra Health


For Investor Inquiries:

Ben Shamsian

Vice President

Lytham Partners, LLC